French medical device company SafeHeal has reported positive results from a clinical study conducted for its Colovac bypass sheath in patients undergoing colorectal surgery.
The first-in-human single-arm 15-patient study was aimed at evaluating the safety and efficacy of the Colovac device in the protection of colorectal anastomosis in adult patients.
During the study phase, patients received a Colovac implant for a period of two weeks, in place of a diverting ostomy.